Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda P Steenbeek

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
JAMA|February 2, 2026
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus StatementsJurgen M Piek, Jolijn Schauwaert, Laura Burney Ellis, et al.
Journal of Gynecologic Oncology|November 28, 2018
Factors influencing decision-making around opportunistic salpingectomy: a nationwide surveyMiranda P Steenbeek, Laura A M van Lieshout, Johanna W M Aarts, et al.
Journal of Cardiology|November 24, 2020
No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriersMajke H D van Bommel, Marieke Arts de Jong, Miranda P Steenbeek, et al.
American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Gynecologic Oncology|May 16, 2020
Fallopian tube abnormalities in uterine serous carcinomaMiranda P Steenbeek, Johan Bulten, Marc P L M Snijders, et al.
American Journal of Obstetrics and Gynecology|June 18, 2025
Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II studyTamar A Gootzen, Miranda P Steenbeek, Marleen M H J van Gelder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Gynecologic Oncology|August 30, 2021
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P Steenbeek, Majke H D van Bommel, Marline G Harmsen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2022
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JAMA|February 2, 2026
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus StatementsJurgen M Piek, Jolijn Schauwaert, Laura Burney Ellis, et al.
Journal of Gynecologic Oncology|November 28, 2018
Factors influencing decision-making around opportunistic salpingectomy: a nationwide surveyMiranda P Steenbeek, Laura A M van Lieshout, Johanna W M Aarts, et al.
Journal of Cardiology|November 24, 2020
No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriersMajke H D van Bommel, Marieke Arts de Jong, Miranda P Steenbeek, et al.
American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Gynecologic Oncology|May 16, 2020
Fallopian tube abnormalities in uterine serous carcinomaMiranda P Steenbeek, Johan Bulten, Marc P L M Snijders, et al.
American Journal of Obstetrics and Gynecology|June 18, 2025
Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II studyTamar A Gootzen, Miranda P Steenbeek, Marleen M H J van Gelder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Gynecologic Oncology|August 30, 2021
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategyMiranda P Steenbeek, Majke H D van Bommel, Marline G Harmsen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2022
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, et al.
Pageof 3